# MEPHISTO (Macrophage Phenotype In Metabolic Syndrome With Iron Overload)

> **NCT02066012** · — · UNKNOWN · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 60 (estimated)

## Conditions studied

- Dysmetabolic Iron Overload Syndrome
- Metabolic Syndrome X

## Interventions

- **OTHER:** dysmetabolic iron overload syndrome

## Key facts

- **NCT ID:** NCT02066012
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2014-08
- **Final completion:** 2014-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2014-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02066012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02066012, "MEPHISTO (Macrophage Phenotype In Metabolic Syndrome With Iron Overload)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02066012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*